Abstract
Introduction
Prostate cancer is a disease of extensive metastases, with secondary lesions in lymph nodes, bones and sometimes in visceral organs, including liver, lungs and even the brain. Actin dynamics is a critical process that modulates cellular activity via regulation of signalling pathways through receptors and cell adhesion to the extracellular matrix (ECM). CD44 is a cell surface receptor and regulator of cell migration and tumour metastasis [1] [2] [3] [4] [5] . We have shown pre viously in prostate cancer cells (PC3) that surface expression of CD44 and formation of CD44-Matrix metalloproteinase 9 (MMP9) complex generates motility enhancing signals through the degradation of ECM proteins 6, 7 . These cells use invadopodia-like structures for invasion into ECM. Localisation of MMP9 in the invadopodia assists in the focal degradation of matrix during invasion 7 . Signalling and actin-binding proteins (e.g. Src, cortactin, WASP and Arp2/3) have been shown to contribute to the formation of invadopodia [8] [9] [10] [11] [12] . CD44 receptor has the potential to inte grate adhesive and signalling activities to modulate migration/invasion processes during cancer progression. CD44 shares some properties with the integrin receptor. Similar to integrin, the cytoplasmic domain of CD44 associates with several proteins involved in signalling and actin dynamics 13, 14 . However, the role of CD44 in the form ation of invadopodia is not clear.
PC3 cells knockdown of MMP9 (PC3/MMP9-/-) are highly adhesive which is due to the expression of highly glycosylated CD44 variant isoform v6. These cells are less invasive due to a deficiency in the expression of standard CD44 (CD44s) and failure in the formation invadopodia 2 . Pertinent to proteins that CD44 interacts with, it is highly possible that CD44 might regulate the formation of invadopodia. Therefore, we hypothesise that similar to integrins, CD44 associates with proteins involved in signalling, and these, in turn, are associated with actin and actin-binding proteins. We show here that Src has a direct role in the formation of invadopodia through its interaction with CD44. CD44-associated signalling complex (Src, WASP, cortactin and Arp2/3) regulates the process of actin polymerisation involved in invadopodia formation.
Materials and Methods
The protocol of this study has been approved by the relevant ethical committee related to our institution in which it was performed.
Antibodies towards CD44, MMP9, Src, WASP, cortactin and cortactin (Y421) were bought from Santo Cruz Biotechnology, Inc. (Santa Cruz, CA). An antibody towards phosphoSrc Y418 was obtained from Cell Signalling (Beverly, MA). Rhodamine phalloidin and other chemicals were purchased from Sigma. CY2 and CY3 conjugated secondary antibodies were purchased from Jackson Immuno Research Laboratories, Inc. (West Grove, PA). 
Immunohistochemistry and actin staining
Cells were cultured onto cover slips in a 6-or 12-well dish for 14-16 h at 37°C. Cells were immunostained with antibodies of interest or stained for actin with rhodamine phalloidin as described previously 2, 6 . Cells were scanned in a Bio-Rad 6000 (Hercules, CA) confocal microscope and images were processed by the Adobe Photoshop program (Adobe Systems, Inc., Mountain View, CA).
Measurement of F-actin content using rhodamine phalloidin binding to PC3 cells PC3 cells cultured in 24 culture plates were subjected to various treatments. For each treatment, six wells were used. Cells were labelled with rhodamine phalloidin (1:200) and processed as described previously 18 .
Gelatin degradation and wound healing assays
Gelatin degradation was performed essentially as described previously 6 .
Statistical analysis
All values presented as mean ± SEM. A value of p < 0.05 was considered significant. Statistical significance was determined by analysis of variance (ANOVA) with the Bonferonni corrections (Instat for IBM; Graph pad software).
Results

Src regulates the formation of invadopodia in PC3 cells
To determine the functional significance of c-Src in the formation of invadopodia, PC3 cells were infected with adenovirus containing CA-and KD-Src as shown previously 17 . An increase in the phosphorylation of Src at Y418 corresponds with the increased levels of Src in PC3 cells transfected with CA-Src ( Figure 1A and B, lane 1) as compared with control cells ( Figure  1A and B, lane 3) . Src phosphorylation in PC3 cells expressing KD-Src is significantly lower ( Figure 1B, lane 2) than the control cells ( Figure 1B, lane  3) , although the expression levels of KD-Src and CA-Src are equal ( Figure  1A, lanes 1 and 2) .
Actin staining in these cells displayed an increase in the number of invadopodia in CA-Src expressing cells ( Figure 1C ) as compared with untransfected (-) cells ( Figure 1E ). An increase in the number of invadopodia corresponds with an increase in F-actin content in PC3 cells expressing CA-Src ( Figure 1F ). The number of invadopodia and F-actin content are significantly reduced below the control levels in KD-Src expressing cells ( Figure 1D and F) . Taken together, these results suggest that Src has a role in actin dynamics invol ved in the formation of invadopodia.
Src regulates surface expression of CD44
We 
Src regulates CD44-associated complex formation
We proceeded to determine the role of Src in CD44-associated complex formation. We show here that Src regulates the phosphorylation state of WASP and cortactin ( Figure 3A and B, lane 1). A significant decrease in the phosphorylation below the control level (lane 3) was observed in cells expressing KD-Src (Figure 3A and B; lane 2). Similar result was observed in cells treated with an Src inhibitor (PP2; lane 4 in Figure 3A) . To evaluate the role of Src in CD44-associated signalling complex formation, lysates (400 µg protein) made from PC3 cells expressing CAand KD-Src were immunoprecipitated with an antibody to CD44. The proteins in the complex were resolved equally in two SDS-PAGE analyses and transferred to membranes for immunoblotting analyses. Blots were probed first with an antibody towards CD44 ( Figure 3C ) and WASP ( Figure 3D ). Subsequently, these blots were stripped and blotted, respectively, with an antibody towards cortactin ( Figure 3E ) and Src ( Figure 3F ). Expression of CA-Src increases the interaction of WASP and cortactin with CD44. Interaction of these proteins is very minimal in cells expressing KD-Src ( Figure 3D and E). Consistent with the observation shown in Figure 2 , Src interacts with CD44. This interaction is seen more in cells expressing CA-Src and less or not observed in KD-Src expressing cells ( Figure 3F) .
To ensure whether similar interaction occurs in the invadopodia of PC3 cells, co-immunostaining of CD44 (green) was performed with WASP, actin, cortactin phospho-specific antibody towards Y421 (p-Cortactin) and Src ( Figure 3G ). It should be noted that specific co-localisation of CD44 (green) with WASP, actin, p-cortactin and Src was observed in the invadopodia of PC3 cells. The staining levels of individual protein are varied in the cytoplasm and membrane ( Figure 3G ).
Knockdown of CD44 and expression of KD-Src in PC3 cells reduces the invasive property of PC3 cells
We have shown earlier that invadopodia forms a focal degradation on the gelatin matrix 7 . The effect of the expression of CA-Src and KD-Src as well as the knockdown of CD44 in the regulation of matrix degradation was determined ( Figure 4 ). An increase in the number of invadopodia corresponds with the invasive nature of PC3 cells expressing CA-Src ( Figures 1C and 4C) . The depth and surface area of degradation was found to be more in CASrc ( Figure 4C 
Discussion
Changes in the phenotype and architecture of cytoskeleton in PC3/ MMP9-/-suggest that CD44 may play a role in the formation of invadopodia and invasion in PC3 cells 2 . Therefore, to best characterise the function of CD44 in invadopodia formation and invasion/migration processes, we used PC3 cells to stably knockdown of CD44. Neither invadopodia nor focal adhesions were signalling involved invadopodia formation and is corroborated by the effects observed with a Src inhibitor (PP2). Cortactin phosphorylation is upregulated by oncogenes (e.g. Src) and growth factors and it was shown to play a role in bone metastasis of breast cancer cells 22, 23 . Cortactin phosphorylated on Y421 is identified in the invadopodia of PC3 cells.
WASP-cortactin constitutes two distinct classes of Arp2/3 modulators. WASP is localised in the invadopodia of PC3 cells 
Conclusion
Our results suggest that CD44-Srccortactin-WASP-Arp2/3 axis plays an important role in the formation of invadopodia. Src also has a role in the surface expression of CD44, which indicates that Src activation may occur independent of CD44 but dependent on integrin signalling. Additional experiments are needed to determine how Src increases the levels of CD44 on the cell surface. We conclude that reducing Src-mediated phosphorylation of cortactin and WASP or depletion of one of the components (e.g. CD44 or cortactin) of ternary complex observed in these cells. Knockdown of CD44 transforms highly invasive PC3 cells into a less adhesive/invasive cellular phenotype. Integrins play organisational roles in the adhesion and formation of invadopodia 19 . Integrin αvβ3 is expressed in PC3 6 as well as PC3/MMP9-/-and PC3/CD44-/-cells (data not shown). However, integrin αvβ3 is not able to compensate for CD44 deficiency in the organisation of invadopodia in PC3/MMP9-/-and PC3/CD44-/-cells. Taken together, these observations suggest the importance of CD44 and the link between CD44 and actin dynamics in the organisation of invadopodia.
Highly invasive cancer cells and Src-transformed cells display actinenriched invadopodia 20 . Src kinase is the most ubiquitously expressed non-receptor tyrosine kinase. Src has been shown to localise in the invadopodia of mammary carcinoma cells where it specifically mediates the phosphorylation of cortactin. As shown by others in human cancer cells 11, 23 , the ability of Src to induce 
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